| Hans-Günter Meyer-Thompson | HIV
GlaxoSmithKline and Gilead to Face Off At HIV Meeting Next Week
GlaxoSmithKline and Gilead Sciences will vie for business in treating HIV patients next week when both companies unveil clinical trial results at a medical meeting in Seattle. (Reuters Health Information, 09.02.2017)